Moreover, Wang et al. (2019) postulated that MALAT1 levels were significantly upregulated in the pulmonary arteries of patients with pulmonary hypertension that can be matched to the pulmonary arteries in the control group. The gene discussed is MALAT1; the disease is pulmonary hypertension.